<?xml version="1.0" encoding="UTF-8" standalone="yes"?><oembed><version><![CDATA[1.0]]></version><provider_name><![CDATA[Glenn Chan&#039;s Random Notes on Investing]]></provider_name><provider_url><![CDATA[https://glennchan.wordpress.com]]></provider_url><author_name><![CDATA[GlennC]]></author_name><author_url><![CDATA[https://glennchan.wordpress.com/author/glennchan/]]></author_url><title><![CDATA[NRCIB: the business has grown but the share price has stayed the&nbsp;same]]></title><type><![CDATA[link]]></type><html><![CDATA[<p><em>(*Disclosure:  Long NRCIB.)</em></p>
<p>Idea type:  GARP and/or share class arbitrage</p>
<p>Three years ago, I wrote about <a href="https://glennchan.wordpress.com/2013/09/06/national-research-corporation-nrciab/">National Research Corporation</a>, an obscure and illiquid company with a market cap of half a billion.  Since then, the company has continued to grow (around 11-14%/year) while the share price has stayed the same.  According to the <a href="https://www.sec.gov/Archives/edgar/data/70487/000143774916026817/nrci20151119_10k.htm">2015 10-K</a>, EPS for class B shares was <strong>$2.52</strong> so the GAAP P/E is around <strong>14</strong>.  However, due to this company&#8217;s unusual structure, GAAP earnings overstate the true P/E.</p>
<p>The arbitrage trade might also be interesting since the spread between the B and A shares should be somewhere around <strong>1:1 to 6:1 or higher (arguably close to 6:1)</strong>, but is currently <strong>2.16:1</strong>.</p>
<p><!--more--></p>
<p>Here&#8217;s a recap of the capital structure:</p>
<ol>
<li>If the company distributes ALL cash flows via dividends, then each B share will receive <strong>6X</strong> the cash that each A share will.</li>
<li>If the company is immediately liquidated or sold, then each B share will receive <strong>1X</strong> the cash that each A share will.</li>
<li>The B shares have more voting power.  So, the class B shareholders have a vested interest in ensuring that most of the company&#8217;s cash flows will be distributed via dividends.</li>
<li>The CEO may be an extremely ethical individual- his excellent shareholder letters talk about how he doesn&#8217;t want to rip off his shareholders via share repurchases.  He may not necessarily abuse his voting power to ensure that the B shares are worth closer to 6X rather than 1X.</li>
</ol>
<p>So, the economic value of the B shares is somewhere between 1:1 to 6:1 that of the A shares.  In my opinion, it should be closer to 6:1 since the B shareholders will likely avoid a liquidation or sale of the company as mentioned earlier.  GAAP earnings are calculated with a 6:1 ratio, though you should ignore that.</p>
<p>The B shares arguably deserve a premium for the higher voting power.  However, in practice there are situations where super-voting shares trade occasionally at a discount (e.g. the Malone empire, Lennar, etc. etc.).</p>
<h2>Lending your shares out</h2>
<p>If you lend out your NRCIB shares, your broker may pay you several percent.  <strong>This situation is a little strange to me</strong>.  It seems like somebody thinks that the shares should trade closer to a 1:1 ratio&#8230; which strikes me as misguided.</p>
<p>In any case, if you are able to lend out your shares, then you would enjoy a tailwind on a long position in NRCIB shares.</p>
<h2>Correction</h2>
<p>In my <a href="https://glennchan.wordpress.com/2013/09/06/national-research-corporation-nrciab/">original writeup</a>, I said that an increase in the share prices of both classes would cause your arbitrage trade to lose money.  That is not necessarily true.  Suppose you go long $1M of NRCIB shares and short $1M of NRCIA shares.  If the share prices of both share classes double, then your profit and loss would be flat.</p>
<p>Instead of shorting 6 A shares for every B share long, you can short ~2.7 A shares for every B share long.</p>
<h2>Please do your own homework</h2>
<p>I don&#8217;t understand National Research&#8217;s industry&#8230; so I&#8217;m at a disadvantage.</p>
<p><em>*Disclosure:  Long NRCIB.  No short position in NRCIA.<br />
</em></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h2>Links</h2>
<p><a href="https://glennchan.wordpress.com/2013/09/06/national-research-corporation-nrciab/">Original writeup on National Research</a></p>
<p><a href="https://glennchan.wordpress.com/2014/02/11/nrcib-closed-my-position-for-silly-reasons/">NRCIB: Closed my position for silly reasons</a></p>
]]></html></oembed>